000			01976 a2200589 4500
005			20250514215709.0
264		0	_c20050714
008			200507s 0 0 eng d
022			_a0394-6320
024	7		_a10.1177/039463200501800116 _2doi
040			_aNLM _beng _cNLM
100	1		_aGuidi, L
245	0	0	_aIncreased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. _h[electronic resource]
260			_bInternational journal of immunopathology and pharmacology _c
300			_a155-64 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aBlotting, Western
650	0	4	_aCrohn Disease _xdrug therapy
650	0	4	_aFemale
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aI-kappa B Proteins _xmetabolism
650	0	4	_aImmunohistochemistry
650	0	4	_aInfliximab
650	0	4	_aIntestinal Mucosa _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMonocytes _ximmunology
650	0	4	_aNF-KappaB Inhibitor alpha
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aPeptide Fragments _xmetabolism
650	0	4	_aTranscription Factors _xmetabolism
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
700	1		_aCostanzo, M
700	1		_aCiarniello, M
700	1		_aDe Vitis, I
700	1		_aPioli, C
700	1		_aGatta, L
700	1		_aPace, L
700	1		_aTricerri, A
700	1		_aBartoloni, C
700	1		_aCoppola, L
700	1		_aBalistreri, P
700	1		_aDoria, G
700	1		_aFedeli, G
700	1		_aGasbarrini, G B
773	0		_tInternational journal of immunopathology and pharmacology _gvol. 18 _gno. 1 _gp. 155-64
856	4	0	_uhttps://doi.org/10.1177/039463200501800116 _zAvailable from publisher's website
999			_c15375097 _d15375097